Wells Fargo’s NRX Pharmaceuticals NRXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.52K | Sell |
2,000
-160
| -7% | -$522 | ﹤0.01% | 5581 |
|
|
2025
Q1 | $4.43K | Hold |
2,160
| – | – | ﹤0.01% | 5576 |
|
|
2024
Q4 | $4.75K | Sell |
2,160
-500
| -19% | -$1.1K | ﹤0.01% | 5568 |
|
|
2024
Q3 | $4.5K | Buy |
2,660
+1,160
| +77% | +$1.96K | ﹤0.01% | 5526 |
|
|
2024
Q2 | $3.66K | Buy |
1,500
+957
| +176% | +$2.34K | ﹤0.01% | 5540 |
|
|
2024
Q1 | $2.56K | Buy |
543
+1
| +0.2% | +$5 | ﹤0.01% | 5596 |
|
|
2023
Q4 | $2.49K | Buy |
542
+4
| +0.7% | +$18 | ﹤0.01% | 5624 |
|
|
2023
Q3 | $1.4K | Buy |
538
+4
| +0.7% | +$10 | ﹤0.01% | 5773 |
|
|
2023
Q2 | $2.58K | Buy |
534
+3
| +0.6% | +$15 | ﹤0.01% | 5868 |
|
|
2023
Q1 | $3.5K | Buy |
531
+1
| +0.2% | +$7 | ﹤0.01% | 5809 |
|
|
2022
Q4 | $5.89K | Buy |
530
+1
| +0.2% | +$11 | ﹤0.01% | 5397 |
|
|
2022
Q3 | $4K | Buy |
529
+6
| +1% | +$45 | ﹤0.01% | 5648 |
|
|
2022
Q2 | $3K | Buy |
523
+23
| +5% | +$132 | ﹤0.01% | 5903 |
|
|
2022
Q1 | $12K | Hold |
500
| – | – | ﹤0.01% | 5856 |
|
|
2021
Q4 | $24K | Hold |
500
| – | – | ﹤0.01% | 5776 |
|
|
2021
Q3 | $46K | Buy |
+500
| New | +$46K | ﹤0.01% | 5344 |
|